Seyfeddinipur N, Gutjahr P, Kutzner J
Strahlentherapie. 1975 Mar;149(3):241-6.
The periods of survival which can be obtained on patients with a primary tumor of the brain after an unique or post-operative cobalt-60-irradiation is dependent of the histology: while periods of survival of several years have been obtained in case of medulloblastoma and astrocytoma, the irradiation of the multiform glioblastoma represents only a palliative measure with a temporary amelioration for any months.
原发性脑肿瘤患者在单次或术后接受钴-60照射后的存活期取决于组织学类型：髓母细胞瘤和星形细胞瘤患者可获得数年的存活期，而多形性胶质母细胞瘤的照射仅为一种姑息性措施，只能使病情暂时缓解数月。
